<unk> (extended-release capsule) is a carbonic anhydrase inhibitor that is FDA approved for the treatment of chronic primary open-angle glaucoma and secondary glaucoma.<unk> is also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.   Common adverse reactions include dizziness and lightheadedness.
Acetazolamide 
Mannitol
Tacalcitol
Brinzolamide
Timolol 
Manidipine
Chlorthalidone
Tropicamide